Inhibition of PI3K/Akt/mTOR Signaling Pathway by Vitis Vinifera Phytocompounds: A Promising Strategy for Supressing Colorectal Cancer Growth and Metastasis

Year : 2023 | Volume : 01 | Issue : 02 | Page : 64-75
By

    Alan S Mathew

  1. Student, Department of Life Science, Kristu Jayanti College (Autonomous), Bengaluru, Karnataka, India

Abstract

Objectives: Colorectal cancer was not typically identified a few decades ago. Today, with almost 900 000 fatalities each year, it is the fourth most dangerous cancer in the world. Colorectal cancer is responsible for about 10% of all cancer diagnoses annually and cancer-related deaths worldwide. It is the second most common type of cancer in women and the third most common type in men. Incidence and death are roughly 25% lower in women than in men. The PI3K/AKT/mTOR signaling system, which controls a wide range of cellular functions including survival, growth, angiogenesis metabolism, proliferation, and metastasis, is hyperactivated or changed in many cancer forms. Hence these proteins may be considered as therapeutic targets to supress colorectal cancer. In this study, the targeted proteins implicated in the etiology of various malignancies were examined for their pharmacological properties and therapeutic impact using the phytochemical components of Vitis vinifera.
Methods: In this study, 203 phytochemicals from Vitis vinifera were selected to evaluate their compatibility with the PI3K, AKT, and mTOR target proteins. A virtual tool called PyRx was used to carry out the molecular docking. Data and molecular structures of the phytocompounds and proteins obtained from Indian medicinal plants, phytochemistry, and therapies, as well as PubChem, were used in the computer analysis. Several technologies, such as BIOVIA discovery studio software and PDBsum generator, were used to validate the protein structure. Using ADMET filters, the ligands’ pharmacological evaluation was performed.
Result: According to the results of molecular docking, the ligands Lupeol , 4-[(2R,3R)-3-(3,5-dihydroxyphenyl)-6-hydroxy-4-[(Z)-2-(4-hydroxyphenyl)vinyl]-2,3-dihydrobenzofuran-2-yl]benzene-1,2-diol, Procyanidin Dimer B7, Procyanidin B1, and Vitamin E had the highest binding affinity towards the three targeted proteins.
Conclusion: These substances could make a good candidate for the management and suppression of cancer because they are effective against the proteins implicated in cancer development. To support these findings, in vitro study is still needed.

Keywords: Cancer, colorectal cancer, vitis vinifera, phosphatidylinositol 3-kinase, mammalian target of rapamycin, phytocompounds, docking

[This article belongs to International Journal of Cell Biology and Cellular Functions(ijcbcf)]

How to cite this article: Alan S Mathew Inhibition of PI3K/Akt/mTOR Signaling Pathway by Vitis Vinifera Phytocompounds: A Promising Strategy for Supressing Colorectal Cancer Growth and Metastasis ijcbcf 2023; 01:64-75
How to cite this URL: Alan S Mathew Inhibition of PI3K/Akt/mTOR Signaling Pathway by Vitis Vinifera Phytocompounds: A Promising Strategy for Supressing Colorectal Cancer Growth and Metastasis ijcbcf 2023 {cited 2023 Oct 24};01:64-75. Available from: https://journals.stmjournals.com/ijcbcf/article=2023/view=128807

Browse Figures

References

  1. Torre, L. A., Siegel, R. L., Ward, E. M. & Jemal, A. Global cancer incidence and mortality rates and trends – An update. Cancer Epidemiol. Biomarkers Prev. 25, 16–27 (2016).
  2. Brenner, H., Kloor, M. & Pox, C. P. Colorectal cancer. Lancet 383, 1490–1502 (2014).
  3. Markowitz, S. D., Dawson, D. M., Willis, J. & Willson, J. K. V. Focus on colon cancer. Cancer Cell 1, 233–236 (2002).
  4. Mármol, I., Sánchez-de-Diego, C., Dieste, A. P., Cerrada, E. & Yoldi, M. J. R. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. Int. J. Mol. Sci. 18, (2017).
  5. Markowitz, S. D. & Bertagnolli, M. M. Gene-Gene Colorectal Cancer. (2009).
  6. Karar, J. & Maity, A. PI3K/AKT/mTOR Pathway in Angiogenesis. Front. Mol. Neurosci. 4, 1–8 (2011).
  7. Alzahrani, A. S. PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside. Semin. Cancer Biol. 59, 125–132 (2019).
  8. Ersahin, T., Tuncbag, N. & Cetin-Atalay, R. The PI3K/AKT/mTOR interactive pathway. Mol. Biosyst. 11, 1946–1954 (2015).
  9. Polivka, J. & Janku, F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol. Ther. 142, 164–175 (2014).
  10. Noorolyai, S., Shajari, N., Baghbani, E., Sadreddini, S. & Baradaran, B. AC PT CR. Gene #pagerange# (2019) doi:10.1016/j.gene.2019.02.076.
  11. Fruman, D. A. et al. Review The PI3K Pathway in Human Disease. Cell 170, 605–635 (2017).
  12. Santis, M. C. De, Gulluni, F., Campa, C. C., Martini, M. & Hirsch, E. PT US CR. BBA – Rev. Cancer (2019) doi:10.1016/j.bbcan.2019.03.003.
  13. Yap, T. A., Bjerke, L., Clarke, P. A. & Workman, P. ScienceDirect Drugging PI3K in cancer : refining targets and therapeutic strategies. Curr. Opin. Pharmacol. 23, 98–107 (2015).
  14. Revathidevi, S. & Munirajan, A. K. SC. Semin. Cancer Biol. (2019) doi:10.1016/j.semcancer.2019.06.002.
  15. Shariati, M. & Meric-bernstam, F. ce pt us t. Expert Opin. Investig. Drugs 0, 1 (2019).
  16. Song, M., Bode, A. M., Dong, Z. & Lee, M. AKT as a Therapeutic Target for Cancer. 1–14 (2019) doi:10.1158/0008-5472.CAN-18-2738.
  17. Murugan, A. K. na of. Semin. Cancer Biol. (2019) doi:10.1016/j.semcancer.2019.07.003.
  18. Hua, H. et al. Targeting mTOR for cancer therapy. 1, 1–19 (2019).
  19. s41598-018-22631-z @ www.nature.com. https://www.nature.com/articles/s41598-018-22631-z#citeas (2018).
  20. R.P. Vivek-Ananth, Karthikeyan Mohanraj, Ajaya Kumar Sahoo, and A. S. Imppat. https://pubs.acs.org/doi/10.1021/acsomega.3c00156 (2023).
  21. Kim, S. et al. PubChem 2023 update. Nucleic Acids Res. 51, D1373–D1380 (2023).
  22. Berman, H. M. The Protein Data Bank. Nucleic Acids Res. 28, 235–242 (2000).
  23. Kuipers, E. J. et al. Colorectal cancer. Nat. Rev. Dis. Prim. 1, 1–25 (2015).
  24. Tewari, D., Patni, P., Bishayee, A., Sah, A. N. & Bishayee, A. of. Semin. Cancer Biol. (2019) doi:10.1016/j.semcancer.2019.12.008.
  25. Products, G. Anticancer and Cancer Chemopreventive Potential of Grape Seed Extract and Other. (2009) doi:10.3945/jn.109.106864.1806S.
  26. Nassiri-asl, M. & Hosseinzadeh, H. Review of the Pharmacological Effects of Vitis vinifera ( Grape ) and its Bioactive Constituents : An Update. (2016).

Regular Issue Subscription Original Research
Volume 01
Issue 02
Received August 6, 2023
Accepted September 18, 2023
Published October 24, 2023